H-DL-Asu-OH

H-DL-Asu-OH is a racemic amino acid derivative corresponding to DL-asparagine acid (Asu) in its free acid form, featuring an amino functionality and a carboxylic acid suitable for peptide coupling chemistry. The side chain contains an additional carboxyl group relative to aspartic acid, which can participate in salt formation, hydrogen bonding, and controlled derivatization during synthesis. The DL stereochemical designation indicates a mixture of enantiomers at the α-carbon, which affects stereoselective incorporation into chiral peptide sequences and downstream stereochemical interpretation. As a small, polar amino acid building block, H-DL-Asu-OH is typically handled as an intermediate for protected amino acid synthesis or for conversion into activated derivatives used in peptide construction and functional group transformation.

1. Peptide Synthesis

H-DL-Asu-OH is applied in peptide synthesis workflows where an aspartate-like side chain bearing an extra carboxyl group is required for charge-rich peptide segments and for subsequent side-chain functionalization. The free amino and carboxylic acid groups enable conversion to coupling-ready forms, while the additional side-chain carboxyl group can be protected or selectively deprotected to control chemoselectivity during iterative assembly. Racemic stereochemistry supports the preparation of non-stereodefined peptide analogs, including screening libraries where stereochemical composition is treated as an experimental variable. Downstream use commonly includes generating peptide building blocks that can be incorporated into amide linkages and then converted into charged or crosslinkable motifs for structure-function studies.

2. Amino Acid Derivatization

H-DL-Asu-OH is suitable for amino acid derivatization and intermediate preparation in synthetic organic chemistry, leveraging its dual carboxyl functionality and primary amine for orthogonal functional group manipulation. The α-carboxyl and side-chain carboxyl groups can be transformed into esters, amides, or activated acid derivatives to tune solubility and reactivity during process chemistry intermediate stages. The amino group can be protected using standard N-protection strategies to enable selective chemistry at the carboxyl groups, supporting routes to protected amino acid derivatives and C-terminal or side-chain modified analogs. Racemic composition can be maintained for bulk intermediate supply when stereochemical purity is not required, enabling scalable access to functionalized aspartate-like motifs.

3. Chiral Building Block Development

H-DL-Asu-OH serves as a starting material for chiral building block development where DL material is converted into stereochemically defined derivatives through resolution, asymmetric synthesis, or stereoselective downstream transformations. The presence of a single α-chiral center allows stereochemical assignment to be introduced at the amino acid stage, and the additional side-chain carboxyl group provides a handle for diastereomeric control when forming protected intermediates or activated derivatives. N-protection and carboxyl protection strategies can be used to create separable diastereomeric intermediates that feed into stereodefined peptide coupling chemistry. The resulting enantiopure or enriched Asu-derived building blocks may then be used to construct chiral peptide analogs and to interpret stereochemistry-dependent outcomes in biochemical research.

4. Bioconjugation Chemistry

H-DL-Asu-OH is utilized in bioconjugation chemistry as a polar amino acid scaffold for introducing additional acidic functionality into linker systems and conjugate precursors. The amino group and carboxyl groups can be converted into amide-forming or activated-carboxyl intermediates that participate in coupling to proteins, peptides, or polymer backbones bearing complementary nucleophiles. Side-chain carboxyl density supports designing conjugates with defined charge characteristics, which can influence solubility, binding interactions, and conjugate stability in analytical and materials contexts. Racemic incorporation can be applied when conjugate stereochemistry is not the primary variable, while controlled protection/deprotection enables selective attachment at the desired functional handle.

5. Analytical Research Standards

H-DL-Asu-OH is applied in analytical research as an amino acid reference material and derivatization substrate for method development in amino acid profiling and peptide hydrolysate analysis. The free amino and carboxylic acid functionalities support derivatization strategies used in chromatographic detection, while the extra side-chain carboxyl group provides a distinctive retention and derivatization behavior compared with simpler amino acids. Racemic composition enables calibration for DL-containing samples and supports interpretation of stereochemical mixtures generated during synthesis or degradation studies. Downstream, Asu-derived standards and labeled or derivatized analogs can be prepared from H-DL-Asu-OH to support quality control of peptide building block preparation and to verify functional group integrity after coupling and deprotection steps.

6. Pharmaceutical Intermediate Preparation

H-DL-Asu-OH is relevant to pharmaceutical intermediate preparation and fine chemical synthesis where aspartate-like, dicarboxylic amino acid motifs are incorporated into peptidomimetic scaffolds and polar linker units. The amino acid functionality supports conversion into protected N-derivatives for controlled amide bond formation, while the dual carboxyl groups allow design of C-terminal modifications and side-chain activation for subsequent coupling steps. Protection-group strategies can be used to manage chemoselectivity between α- and side-chain carboxyl reactivity during multi-step synthesis toward peptide-like intermediates. Industrially, racemic availability can be leveraged for bulk intermediate supply when stereochemical purity is addressed later in the route or when the target structure tolerates DL composition, supporting scalable preparation of amino acid-derived building blocks for applied chemical manufacturing.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Emu oil in combination with other active ingredients for treating skin imperfections